Skip to content
Screener

Bio-Rad Laboratories BIO Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$651M-0.1%$592.1M+1.1%$693.2M+3.9%$653M+0.5%$651.6M+2.1%
$305.2M-0.4%$282.7M+1.2%$348M+6.9%$309.6M+5.4%$306.3M+8.1%
$345.8M+0.1%$309.4M+1.1%$345.2M+0.9%$343.4M-3.5%$345.3M-2.8%
53.1%+0.1pp52.3%0.0pp49.8%-1.4pp52.6%-2.2pp53%-2.6pp
$61.2M+1.2%$62.9M-14.4%$70.3M-11.7%$71.3M-21.6%$60.5M+2.7%
$212M+2.1%$212.4M+1.7%$221M+8.3%$206.8M+3.2%$207.7M+6.7%
$72.6M-5.8%$34.1M+43.9%——$65.3M+1.2%$77.1M-24.0%
11.2%-0.7pp5.8%+1.7pp——10%+0.1pp11.8%-4.1pp
$12.1M-4.0%$12.3M+2.5%$12.1M-0.8%$12.3M+1.7%$12.6M+2.4%
$23.4M+44.4%$24.2M-34.9%$28.6M+45.9%$8.3M-53.6%$16.2M-11.0%
$542.1M+30.9%-$689.8M-927%$929.2M+202%-$431.1M-150%$414M+115%
$170.7M+77.4%-$162.7M-939%$209.2M+208%-$89.2M-143%$96.2M+115%
$371.4M+16.9%-$527.1M-924%$720M+201%-$341.9M-152%$317.8M+115%
57.1%+8.3pp-89%-100.0pp103.9%+211pp-52.4%-153pp48.8%+388pp
$13.85+18.7%-$19.55-954%$26.39+203%-$12.70-154%$11.67+115%
$119.7M-2.6%$80.9M+21.1%——$116.8M+7.5%$122.9M-14.2%
18.4%-0.5pp13.7%+2.3pp——17.9%+1.2pp18.9%-3.6pp
$72.6M-5.8%$34.1M+43.9%$941.3M+1,515%$65.3M+1.2%$77.1M-24.0%

FAQ

What is Bio-Rad Laboratories's revenue?
Bio-Rad Laboratories (BIO) generated $2.6B in revenue over the trailing twelve months, up 1.4% year over year.
Is Bio-Rad Laboratories profitable?
Bio-Rad Laboratories reported $222.4M in net income over the trailing twelve months, a 8.6% net margin.
What are Bio-Rad Laboratories's profit margins?
Gross margin is 51.9% and operating margin is 8.8%, with a 8.6% net margin.
What is Bio-Rad Laboratories's earnings per share?
Bio-Rad Laboratories's diluted EPS over the trailing twelve months is $7.99.
Where does Bio-Rad Laboratories's income statement data come from?
Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.